H. Lundbeck AS (FRA:LDBA) Buildings And Improvements: €0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LDBA H. Lundbeck AS FRA:LDBA
79 GF Score
Price €5.91
GF Value €5.20
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is H. Lundbeck AS Buildings And Improvements?

H. Lundbeck AS FRA:LDBA -0.25% 79 Buildings And Improvements is €0 Mil as of Jun. 2026. GuruFocus rates FRA:LDBA with a GF Score™ of 79/100 and a GF Value™ of €5.20 (Modestly Overvalued). The stock has 5 warning signs investors should review.

H. Lundbeck AS's quarterly buildings and improvements declined from Dec. 2025 (€123 Mil) to Mar. 2026 (€0 Mil) but then stayed the same from Mar. 2026 (€0 Mil) to Jun. 2026 (€0 Mil).

H. Lundbeck AS's annual buildings and improvements increased from Dec. 2023 (€101 Mil) to Dec. 2024 (€122 Mil) and increased from Dec. 2024 (€122 Mil) to Dec. 2025 (€123 Mil).

H. Lundbeck AS Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for H. Lundbeck AS's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H. Lundbeck AS Buildings And Improvements Chart

H. Lundbeck AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.81 98.26 101.43 122.29 123.04

H. Lundbeck AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 123.04 0.00 0.00
FRA:LDBA
79GF Score
H. Lundbeck AS FRA:LDBA
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H. Lundbeck AS Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of €0 Mil mean?
H. Lundbeck AS (FRA:LDBA) has a Buildings And Improvements of €0 Mil as of Jun. 2026. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on H. Lundbeck AS and its competitors.
Is H. Lundbeck AS's Buildings And Improvements too high?
H. Lundbeck AS's current Buildings And Improvements is €0 Mil. Overall, H. Lundbeck AS has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H. Lundbeck AS's Buildings And Improvements compare to ZTS and UTHR?
H. Lundbeck AS's Buildings And Improvements of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Drug Manufacturers company?
A good Buildings And Improvements depends on the Drug Manufacturers industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on H. Lundbeck AS and its competitors. H. Lundbeck AS's current Buildings And Improvements is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H. Lundbeck AS stock overvalued right now?
Based on GuruFocus' analysis, H. Lundbeck AS (FRA:LDBA) is currently considered Modestly Overvalued. The stock's GF Value™ is €5.20, compared to a current price of €5.91 — trading 13.6% above its estimated fair value. The current Buildings And Improvements is €0 Mil. H. Lundbeck AS's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For H. Lundbeck AS (FRA:LDBA), the current Buildings And Improvements is €0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H. Lundbeck AS (FRA:LDBA) Overvalued in 2026?

Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be overvalued. The current stock price of €5.91 is trading 13.6% above its estimated GF Value™ of €5.20. GuruFocus considers H. Lundbeck AS to be Modestly Overvalued.

Key valuation signals for FRA:LDBA:

  • Buildings And Improvements: €0 Mil
  • GF Value™: €5.20 vs. price of €5.91 (13.6% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the FRA:LDBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H. Lundbeck AS Business Description

Address Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
79GF Score

Get the complete analysis for FRA:LDBA

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.91
Price
€5.20
GF Value